KNSA Competitors & Alternatives

Compare Kiniksa Pharmaceuticals Ltd with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

KNSA

Main Stock
$73.41
Tradestie Score
58
Market Cap
$2.86B
P/E Ratio
82.3
Revenue Growth
0.6%
Analyst Upside
+33.5%

Top Competitors

45 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
RGC Regencell Bioscience Holdings Limited Ordinary Shares
$6.13
$7.83B - 45 Compare
RYTM Rhythm Pharmaceuticals, Inc. Common Stock
$102.78
$6.64B - 60 Compare
KRYS Krystal Biotech, Inc. Common Stock
$312.57
$5.20B 45.7 59 Compare
ALKS Alkermes Inc. plc
$49.53
$5.06B 128.9 58 Compare
CRNX Crinetics Pharmaceuticals, Inc.
$83.76
$3.92B - 47 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$104.59
$3.67B - 59 Compare
LNTH Lantheus Holdings, Inc
$101.19
$3.51B 23.9 45 Compare
SRRK Scholar Rock Holding Corporation Common Stock
$45.85
$3.33B - 52 Compare
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock
$18.85
$3.26B 38.2 57 Compare
PBH Prestige Consumer Healthcare Inc.
$51.92
$3.12B 12.8 48 Compare

Data updated: Aug 04, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

45 stocks in this industry